Cargando…
A Sensitive and Controlled Data-Independent Acquisition Method for Proteomic Analysis of Cell Therapies
[Image: see text] Mass spectrometry (MS)-based proteomic measurements are uniquely poised to impact the development of cell and gene therapies. With the adoption of rigorous instrumental performance qualifications (PQs), large-scale proteomics can move from a research to a manufacturing control tool...
Autores principales: | Lombard-Banek, Camille, Pohl, Kerstin I., Kwee, Edward J., Elliott, John T., Schiel, John E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087334/ https://www.ncbi.nlm.nih.gov/pubmed/35404046 http://dx.doi.org/10.1021/acs.jproteome.1c00887 |
Ejemplares similares
-
Mass Spectrometry Advances and Perspectives for the Characterization of Emerging Adoptive Cell Therapies
por: Lombard-Banek, Camille, et al.
Publicado: (2020) -
Single‐Cell Mass Spectrometry for Discovery Proteomics: Quantifying Translational Cell Heterogeneity in the 16‐Cell Frog (Xenopus) Embryo
por: Lombard‐Banek, Camille, et al.
Publicado: (2016) -
Optimization of Data-Independent Acquisition Mass Spectrometry for Deep and Highly Sensitive Proteomic Analysis
por: Kawashima, Yusuke, et al.
Publicado: (2019) -
High-Sensitivity Mass Spectrometry for Probing Gene Translation in Single Embryonic Cells in the Early Frog (Xenopus) Embryo
por: Lombard-Banek, Camille, et al.
Publicado: (2016) -
Characterization of proteome profile data of chemicals based on data-independent acquisition MS with SWATH method
por: Ishiguro, Hiromu, et al.
Publicado: (2023)